Johnson & Johnson: Seizures trials
The registry lists 23 Seizures studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 3 have results posted.
Phase 1 1Phase 2 6Phase 3 10Phase 4 1No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in EpilepsyCompletedNCT04836559Phase 2Results posted
- Clinical Evaluation of Fitting Investigational Contact Lenses Phase 2CompletedNCT03168542Not applicableResults posted
- Clinical Evaluation of Fitting Investigational Contact LensesCompletedNCT03150485Not applicableResults posted
- A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With EpilepsyCompletedNCT01030094
- A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With SeizuresCompletedNCT00297349
- An Observational Study of the Safety of Topiramate in Adults and Children With EpilepsyCompletedNCT00297323
- A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of EpilepsyCompletedNCT00266604Phase 4
- A Study of the Efficacy and Safety of Topiramate Treatment in Patients With EpilepsyCompletedNCT00266591Phase 3
- Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy PatientsCompletedNCT00236886Phase 3
- A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.CompletedNCT00236873Phase 2
- A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset SeizuresCompletedNCT00236860Phase 2
- A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.CompletedNCT00236847Phase 2
- A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut SyndromeCompletedNCT00236756Phase 3
- A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With EpilepsyCompletedNCT00236743Phase 3
- A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control EpilepsyCompletedNCT00236730Phase 2
- A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With EpilepsyCompletedNCT00236717Phase 3
- A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic SeizuresCompletedNCT00236704Phase 3
- A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.CompletedNCT00236691Phase 2
- A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic SeizuresCompletedNCT00236418Phase 3
- A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset SeizuresCompletedNCT00233012Phase 1
- A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent EpilepsyCompletedNCT00231556Phase 3
- A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset SeizureCompletedNCT00230698Phase 3
- Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset SeizuresCompletedNCT00113815Phase 3